rs36049418

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001126108.2(SLC12A3):​c.2182G>A​(p.Ala728Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0188 in 1,609,578 control chromosomes in the GnomAD database, including 372 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 19 hom., cov: 30)
Exomes 𝑓: 0.019 ( 353 hom. )

Consequence

SLC12A3
NM_001126108.2 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.13
Variant links:
Genes affected
SLC12A3 (HGNC:10912): (solute carrier family 12 member 3) This gene encodes a renal thiazide-sensitive sodium-chloride cotransporter that is important for electrolyte homeostasis. This cotransporter mediates sodium and chloride reabsorption in the distal convoluted tubule. Mutations in this gene cause Gitelman syndrome, a disease similar to Bartter's syndrome, that is characterized by hypokalemic alkalosis combined with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. This cotransporter is the target for thiazide diuretics that are used for treating high blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009306401).
BP6
Variant 16-56887928-G-A is Benign according to our data. Variant chr16-56887928-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 403447.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56887928-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0128 (1932/151094) while in subpopulation NFE AF= 0.0196 (1330/67804). AF 95% confidence interval is 0.0187. There are 19 homozygotes in gnomad4. There are 901 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC12A3NM_001126108.2 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 26 ENST00000563236.6 NP_001119580.2 P55017-1
SLC12A3NM_000339.3 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 26 NP_000330.3 P55017-2
SLC12A3NM_001126107.2 linkc.2179G>A p.Ala727Thr missense_variant Exon 18 of 26 NP_001119579.2 P55017-3
SLC12A3NM_001410896.1 linkc.2179G>A p.Ala727Thr missense_variant Exon 18 of 26 NP_001397825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC12A3ENST00000563236.6 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 26 1 NM_001126108.2 ENSP00000456149.2 P55017-1
SLC12A3ENST00000438926.6 linkc.2182G>A p.Ala728Thr missense_variant Exon 18 of 26 1 ENSP00000402152.2 P55017-2
SLC12A3ENST00000566786.5 linkc.2179G>A p.Ala727Thr missense_variant Exon 18 of 26 1 ENSP00000457552.1 P55017-3
SLC12A3ENST00000262502.5 linkc.2179G>A p.Ala727Thr missense_variant Exon 18 of 26 5 ENSP00000262502.5 J3QSS1

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1933
AN:
150986
Hom.:
19
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00410
Gnomad AMI
AF:
0.0703
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0107
Gnomad FIN
AF:
0.00752
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0196
Gnomad OTH
AF:
0.0121
GnomAD3 exomes
AF:
0.0121
AC:
3042
AN:
251000
Hom.:
39
AF XY:
0.0129
AC XY:
1749
AN XY:
135796
show subpopulations
Gnomad AFR exome
AF:
0.00364
Gnomad AMR exome
AF:
0.00463
Gnomad ASJ exome
AF:
0.0115
Gnomad EAS exome
AF:
0.000163
Gnomad SAS exome
AF:
0.00934
Gnomad FIN exome
AF:
0.00989
Gnomad NFE exome
AF:
0.0187
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.0194
AC:
28262
AN:
1458484
Hom.:
353
Cov.:
30
AF XY:
0.0189
AC XY:
13750
AN XY:
725638
show subpopulations
Gnomad4 AFR exome
AF:
0.00329
Gnomad4 AMR exome
AF:
0.00575
Gnomad4 ASJ exome
AF:
0.0111
Gnomad4 EAS exome
AF:
0.0000757
Gnomad4 SAS exome
AF:
0.0103
Gnomad4 FIN exome
AF:
0.00936
Gnomad4 NFE exome
AF:
0.0227
Gnomad4 OTH exome
AF:
0.0161
GnomAD4 genome
AF:
0.0128
AC:
1932
AN:
151094
Hom.:
19
Cov.:
30
AF XY:
0.0122
AC XY:
901
AN XY:
73792
show subpopulations
Gnomad4 AFR
AF:
0.00409
Gnomad4 AMR
AF:
0.0115
Gnomad4 ASJ
AF:
0.0124
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0105
Gnomad4 FIN
AF:
0.00752
Gnomad4 NFE
AF:
0.0196
Gnomad4 OTH
AF:
0.0120
Alfa
AF:
0.0170
Hom.:
34
Bravo
AF:
0.0129
TwinsUK
AF:
0.0235
AC:
87
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.00432
AC:
19
ESP6500EA
AF:
0.0197
AC:
169
ExAC
AF:
0.0121
AC:
1465
EpiCase
AF:
0.0196
EpiControl
AF:
0.0183

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hypokalemia-hypomagnesemia Benign:4
Oct 25, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

The heterozygous p.Ala728Thr variant in SLC12A3 has been identified in an individual from the Philippines with Gitelman syndrome (PMID: 8528245), but has also been identified in >1% of European (non-Finnish) chromosomes and 27 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal recessive Gitelman syndrome. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SLC12A3: BP4, BS1, BS2 -

Jan 26, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 27535533, 27884173, 8528245, 20981092, 24633158) -

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 188/12996=1.44% -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
2.7
DANN
Benign
0.86
DEOGEN2
Benign
0.34
.;.;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.76
T;T;T;T
MetaRNN
Benign
0.0093
T;T;T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
0.38
.;N;N;.
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.91
N;N;N;N
REVEL
Benign
0.17
Sift
Benign
0.23
T;T;T;T
Sift4G
Benign
0.71
T;T;T;T
Polyphen
0.0010
B;B;B;.
Vest4
0.053
MPC
0.085
ClinPred
0.00031
T
GERP RS
-0.68
Varity_R
0.064
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs36049418; hg19: chr16-56921840; COSMIC: COSV52635583; API